Position paper of the Italian Association for the Study of the Liver (AISF): Management and treatment of primary biliary cholangitis
- PMID: 38902184
- DOI: 10.1016/j.dld.2024.05.002
Position paper of the Italian Association for the Study of the Liver (AISF): Management and treatment of primary biliary cholangitis
Keywords: Autoimmunity; Bile acids; Cholestasis; Liver.
Conflict of interest statement
Conflict of interest Cristina Rigamonti receives speaking engagements and travel grants from Advanz Pharma, Roche, and Abbvie. Nora Cazzagon receives speaker fees from Intercept and Advanz, and serves on advisory boards for Albireo, IPSEN, and Orphalan, also receiving travel grants from Orphalan and IPSEN. Luigi Muratori has received speaker fees from Advanz. Alessio Gerussi receives speaker fees from Advanz and consults for CAMP4 Therapeutics, Ipsen, and Signant Health. Marco Carbone consults for Ipsen, Advanz, GSK, Albireo, Cymabay, Mayoly, Echosens, and IHEP, and serves on advisory boards for Ipsen, Cymabay, and Dr. Falk.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources